Oyster Point Pharma, Inc. Quarterly Debt-to-equity in % from Q2 2020 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Oyster Point Pharma, Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q3 2022.
  • Oyster Point Pharma, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 353 %, a 2364% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 353 +338 +2364% Sep 30, 2022
Q2 2022 143 +137 +2179% Jun 30, 2022
Q1 2022 69.9 +64.3 +1137% Mar 31, 2022
Q4 2021 36.5 +31 +563% Dec 31, 2021
Q3 2021 14.3 +9.19 +179% Sep 30, 2021
Q2 2021 6.28 -1.28 -16.9% Jun 30, 2021
Q1 2021 5.65 Mar 31, 2021
Q4 2020 5.51 Dec 31, 2020
Q3 2020 5.13 Sep 30, 2020
Q2 2020 7.56 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.